(NASDAQ:XLO), 40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB) Estimate 55% of patients with MSS CRC have high plasma TMB, representing a meaningful population with high unmet need Company to host conference call and webcast on Monday, November 10, 2025, at 4:30 p.m. […]

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting GlobeNewswire November 07, 2025 40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB) Estimate

Lincoln Tech to Expand Presence in Texas with New Rowlett Campus Second Campus in the Dallas Metro Area to Address Underserved Market for Electrical, HVAC, Automotive and Welding Skills Training GlobeNewswire November 07, 2025 Parsippany, NJ, Nov. 07, 2025 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC), a national leader in specialized technical and

Fort Worth, Texas – Nearshore Business Solutions is redefining how U.S. companies build and scale remote teams by providing direct access to highly skilled professionals across Latin America. With a focus on speed, quality, and cost-efficiency, Nearshore Business Solutions is transforming the remote hiring landscape through its in-country recruitment expertise and commitment to client success.

Tests at Scala's Tamboré campus confirmed a latency reduction of approximately 32%, bringing data transmission closer to the speed of light Scala Data Centers, the leading sustainable data center platform for the hyperscale market in Latin America, partnered with Lightera, the brand that integrates Furukawa Electric Co.'s global optical fiber cable operations and a pioneer

— 20%ORR and 80% DCR observed as monotherapy in TMB-H tumors across seven major solid tumor types, including colorectal, lung, breast, gastric, gastroesophageal junction (GEJ), head and neck, and bladder cancers — Clinical activity was consistent across all subgroups and independent of prior PD-1 treatment, with 59% of patients experiencing target-lesion tumor shrinkage Marengo Therapeutics,

MobileFuse, a leading advertising and technology company, today announced that it has received a Platinum Award in the 2025 MarCom Awards, one of the industry's most respected international competitions honoring excellence in marketing and communications. https://mma.prnewswire.com/media/1529978/MobileFuse_Logo.jpg The winning campaign, “Broad Banking Prospects,” was developed by MobileFuse Studio in partnership with Space Coast Credit Union, earning

Transfers listing to the Nasdaq Capital Market NAPLES, FL / ACCESS Newswire / November 7, 2025 / Rain Enhancement Technologies Holdco, Inc. (the "Company") (Nasdaq:RAIN, RAINW), today announced that it has regained compliance with the continued listing requirements of Nasdaq and has transferred the listing of its securities from the Nasdaq Global Market to the

Four-year follow-up demonstrates preserved bowel, urinary, and sexual outcomes with consistent, reproducible spacing Following publication of BioProtect's pivotal randomized trial in the International Journal of Radiation Oncology, Biology, Physics (Red Journal) and presentation of the long-term quality-of-life follow-up analysis at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, BioProtect is sharing new evidence

25-year usage data leader to reveal foundation of “Living Monetization Era” as AI breaks traditional SaaS models DigitalRoute, a global leader in usage data management and monetization infrastructure, will make a major product announcement on November 11, 2025, addressing the “Usage Monetization Drama” – a crisis affecting digital businesses as AI-driven growth breaks SaaS and